4 results on '"Wu, Zhenzhen"'
Search Results
2. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
- Author
-
Wu, Jiani, Zeng, Dongqiang, Zhi, Shimeng, Ye, Zilan, Qiu, Wenjun, Huang, Na, Sun, Li, Wang, Chunlin, Wu, Zhenzhen, Bin, Jianping, Liao, Yulin, Shi, Min, and Liao, Wangjun
- Subjects
PROGNOSIS ,MYELOID-derived suppressor cells ,OVERALL survival ,IMMUNOTHERAPY ,FIBROBLASTS ,TREATMENT effectiveness ,SURVIVAL analysis (Biometry) ,EXOSOMES ,MELANOMA treatment ,RESEARCH ,MELANOMA ,RESEARCH methodology ,CELL physiology ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,RESEARCH funding ,CYTOLOGY - Abstract
Background: Tumor-derived exosomes (TEXs) are involved in tumor progression and the immune modulation process and mediate intercellular communication in the tumor microenvironment. Although exosomes are considered promising liquid biomarkers for disease diagnosis, it is difficult to discriminate TEXs and to develop TEX-based predictive biomarkers.Methods: In this study, the gene expression profiles and clinical information were collected from The Cancer Genome Atlas (TCGA) database, IMvigor210 cohorts, and six independent Gene Expression Omnibus datasets. A TEXs-associated signature named TEXscore was established to predict overall survival in multiple cancer types and in patients undergoing immune checkpoint blockade therapies.Results: Based on exosome-associated genes, we first constructed a tumor-derived exosome signature named TEXscore using a principal component analysis algorithm. In single-cell RNA-sequencing data analysis, ascending TEXscore was associated with disease progression and poor clinical outcomes. In the TCGA Pan-Cancer cohort, TEXscore was elevated in tumor samples rather than in normal tissues, thereby serving as a reliable biomarker to distinguish cancer from non-cancer sources. Moreover, high TEXscore was associated with shorter overall survival across 12 cancer types. TEXscore showed great potential in predicting immunotherapy response in melanoma, urothelial cancer, and renal cancer. The immunosuppressive microenvironment characterized by macrophages, cancer-associated fibroblasts, and myeloid-derived suppressor cells was associated with high TEXscore in the TCGA and immunotherapy cohorts. Besides, TEXscore-associated miRNAs and gene mutations were also identified. Further experimental research will facilitate the extending of TEXscore in tumor-associated exosomes.Conclusions: TEXscore capturing tumor-derived exosome features might be a robust biomarker for prognosis and treatment responses in independent cohorts. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
3. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.
- Author
-
Li, Yue, Wu, Zhenzhen, Yuan, Jia, Sun, Li, Lin, Li, Huang, Na, Liao, Wangjun, Bin, Jianping, and Liao, Yulin
- Subjects
- *
RNA , *VASCULOGENIC mimicry , *NEOVASCULARIZATION , *CATENINS , *CANCER research , *ANTIGEN analysis , *RNA physiology , *GLYCOPROTEIN analysis , *ANIMALS , *CANCER invasiveness , *CAPILLARY permeability , *CELL lines , *CELL physiology , *CELL motility , *CELLULAR signal transduction , *CYTOSKELETAL proteins , *METASTASIS , *MICE , *PROGNOSIS , *STOMACH tumors , *PATHOLOGIC neovascularization - Abstract
MALAT1 is an oncogenic long non-coding RNA that has been found to promote the proliferation of many malignant cell types and non-malignant human umbilical vein endothelial cells (HUVECs). However, the functions of MALAT1 in vasculogenic mimicry (VM) and angiogenesis and the potential mechanisms responsible have not yet been investigated in any malignancy. Here, in situ hybridization and CD31/periodic acid-Schiff double staining of 150 gastric cancer (GC) clinical specimens revealed that MALAT1 expression was tightly associated with densities of VM and endothelial vessels. MALAT1 knockdown markedly reduced GC cell migration, invasion, tumorigenicity, metastasis, and VM, while restricting HUVEC angiogenesis and increasing vascular permeability. Moreover, MALAT1 was found to regulate expression of VE-cadherin, β-catenin, MMPs 2 and 9, MT1-MMP, p-ERK, p-FAK, and p-paxillin, which have been established as classical markers of VM and angiogenesis and components of associated signaling pathways. Consistent with this, the p-ERK inhibitors U0126 and PD98059 both effectively blocked GC cell VM. In conclusion, MALAT1 can promote tumorigenicity and metastasis in GC by facilitating VM and angiogenesis via the VE-cadherin/β-catenin complex and ERK/MMP and FAK/paxillin signaling pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Prognostic Value of MACC1 in Digestive System Neoplasms: A Systematic Review and Meta-Analysis.
- Author
-
Wu, Zhenzhen, Zhou, Rui, Su, Yuqi, Sun, Li, Liao, Yulin, and Liao, Wangjun
- Subjects
- *
CHI-squared test , *DIGESTIVE organs , *CONFIDENCE intervals , *DISEASES , *IMMUNOHISTOCHEMISTRY , *MEDICAL information storage & retrieval systems , *MEDLINE , *META-analysis , *MORTALITY , *ONCOGENES , *ONLINE information services , *POLYMERASE chain reaction , *RESEARCH funding , *TUMOR markers , *SYSTEMATIC reviews , *REVERSE transcriptase polymerase chain reaction , *PUBLICATION bias , *DATA analysis software , *PROGNOSIS , *GENETICS , *TUMORS - Abstract
Metastasis associated in colon cancer 1 (MACC1), a newly identified oncogene, has been associated with poor survival of cancer patients by multiple studies. However, the prognostic value of MACC1 in digestive system neoplasms needs systematic evidence to verify. Therefore, we aimed to provide further evidence on this topic by systematic review and meta-analysis. Literature search was conducted in multiple databases and eligible studies analyzing survival data and MACC1 expression were included for meta-analysis. Hazard ratio (HR) for clinical outcome was chosen as an effect measure of interest. According to our inclusion criteria, 18 studies with a total of 2,948 patients were identified. Pooled HRs indicated that high MACC1 expression significantly correlates with poorer OS in patients with digestive system neoplasms (HR = 1.94; 95% CI: 1.49–2.53) as well as poorer relapse-free survival (HR = 1.94, 95% CI: 1.33–2.82). The results of subgroup studies categorized by methodology, anatomic structure, and cancer subtype for pooled OS were all consistent with the overall pooled HR for OS as well. No publication bias was detected according to test of funnel plot asymmetry and Egger’s test. In conclusion, high MACC1 expression may serve as a prognostic biomarker to guide individualized management in clinical practice for digestive system neoplasms. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.